The reduction by Ed Yardeni, president and chief investment strategist of Yardeni Research, is notable for a few reasons, one ...

What next for the SCHD ETF now that analysts at Citigroup, Goldman Sachs, and HSBC have slashed their S&P 500 forecast?

Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the pricing of an upsized ...

Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the commencement of an underwritten ...

Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of The Goldman Sachs Group, Inc. (NYSE:GS). In a ...

Representative Josh Gottheimer (D-New Jersey) recently sold shares of The Goldman Sachs Group, Inc. (NYSE:GS). In a filing disclosed on March 06th, the Representative disclosed that they had sold ...

Tarsus Pharmaceuticals (TARS) announced the commencement of an underwritten public offering of $100M of shares of its common stock. All shares ...

The Irvine-based biopharmaceutical company today announced the underwritten public offering after market close today.

Stocks dropped as the selling pressures that dragged Wall Street last week persisted, while investors braced for a slew of ...

A version of this article originally appeared in Quartz’s members-only Weekend Brief newsletter. Quartz members get access to ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...